pubrio
Experimental Drug Development Centre (EDDC)

Experimental Drug Development Centre (EDDC)

Singapore · Research

Research

Pharmaceuticals

Biotechnology

Healthcare

The Experimental Drug Development Centre (EDDC) is Singapore's national platform for drug discovery and development. Our goals are to champion local translational drug development efforts and thus catalyze the growth of Singapore's biopharma ecosystem. With a focus on Asian-prevalent diseases, we aim to develop therapeutics and diagnostics that save and improve the lives of patients in Singapore, Asia, and the world beyond. We are dedicated to translating the great science arising from Singapore's biomedical and clinical research into innovative healthcare solutions. EDDC possesses a full range of capabilities for the discovery and development of small molecule drugs, antibody-based drugs, and companion diagnostics. We are keen to establish robust partnerships with academic, clinical, and bio-pharmaceutical industry partners for development and commercialization of innovative assets and platforms. EDDC is committed to jointly bring forward medicines that improve healthcare and generate a return to support Singapore's future drug discovery and development research.

Company Insights
Company Overview

2022

Founded

Research

Industry

Singapore

Location

7,163,185

Ranking

200 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Experimental Drug Development Centre (EDDC)

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​